Cosmetic Industry Deals: ELC/Biotech Partnership Will Further Lauder’s Skin Longevity Push; L’Oréal Cuts Ribbon On $160M US Innovation Center

Estee Lauder Companies, Inc. is collaborating with biotechnology company, Serpin Pharma, to explore how anti-inflammatory research can be applied in cosmetics to deliver significant skin care longevity benefits to consumers. The exclusive deal will “accelerate ELC’s focus on transformative product innovation by applying insights from Serpin Pharma’s two decades of anti-inflammatory research, which has yielded proprietary biotech technology demonstrating remarkable efficacy mitigating harmful inflammation and enhancing cell resiliency,” the firm said.